Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | UPXI Upexi, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.16 +1.8% | $15.90 -2.5% |
| StockIQ Score | 47D+ Moderate Risk: Medium | 41D Weak Risk: High |
| Technical | 63C+ | 36F |
| Fundamental | 46D+ | 35F |
| Growth | 40D | 50C- |
| Fair Value | 38F | 38F |
| News | 32F | 50C- |
| Quality | 47D+ | 50C- |
| Risk | 46D+ | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Upexi (UPXI) outperforms Ascentage Pharma (AAPG) in technical and fundamental scores, with 63 versus 36 and 46 versus 35, respectively. AAPG leads in growth, scoring 50 compared to UPXI’s 40. Both share the same valuation score of 38, but UPXI’s overall investor score (47) is higher than AAPG’s (41). UPXI shows stronger stability, while AAPG has more potential for expansion.
